Experience. Commitment. Results.
Northern Genesis Acquisition Corp. (NGA) relating to its proposed merger with The Lion Electric Co. (“Lion”). Under the terms of the agreement, NGA will acquire Lion through a reverse merger. The combined company will be traded on NYSE as “LEV” and valued at approximately $1.9 billion.
INSU Acquisition Corp. II (INSU) relating to its proposed merger with MetroMile, Inc. (“MetroMile”). Under the terms of the merger agreement, INSU will acquire MetroMile through a reverse merger, with MetroMile becoming a publicly traded company. The promposed transaction has an estimated pro forma value of $956 million.
Roth CH Acquisition I Co. (ROCH) relating to its proposed merger with PureCycle Technologies LLC (“PureCycle”). Under the terms of the merger agreement, Roth shareholders are only expected to own 8.3% of the combined company, while PureCycle shareholders are expected to own a majority 70.6%.
Waddell & Reed Financial, Inc. (WDR) relating to its proposed sale to Macquarie Asset Management. (“Macquarie”). Under the terms of the agreement, WDR shareholders are expected to receive $25.00 per share.
Collectors Universe, Inc. (CLCT) relating to its proposed acquisition by an investor group led by Nat Turner, D1 Capital Partners, L.P., and Cohen Private Ventures, LLC. Under the terms of the all-cash tender offer, CLCT shareholders are expected to receive $75.25 per share.
The Goldfield Corporation (GV) relating to its proposed acquisition by affiliates of First Reserve Fund XIV, L.P.. Under the terms of the agreement, Goldfield shareholders are expected to receive $7.00 per share.
HD Supply Holdings, Inc. (HDS) relating to its proposed acquisition by The Home Depot, Inc. Under the terms of the agreement, HDS shareholders are expected to receive $56.00 per share.
Akers Biosciences, Inc. (AKER) relating to its proposed acquisition by MyMD Pharmaceuticals. Under the terms of the agreement, Akers shareholders are expected to own only 20% of the combined company.
Tengasco, Inc. (TGC) relating to its proposed merger with Riley Exploration – Permian, LLC. Under the terms of the agreement, Tengasco shareholders will only own 5% of the combined company.
Urovant Sciences Ltd. (UROV) relating to its proposed acquisition by Sumitovant Biopharma Ltd. Under the terms of the agreement, Urovant shareholders are expected to receive approximately $16.25 in cash per share.